| Jerome Kwaku Atror, PHARMD | |
|
11012 Canyon Rd E, Puyallup, WA 98373-4200 | |
| (253) 537-1517 | |
| Not Available |
| Full Name | Jerome Kwaku Atror |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 11012 Canyon Rd E, Puyallup, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083367106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 051304362 (Illinois) | Secondary |
| 183500000X | Pharmacist | PH61245518 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jerome Kwaku Atror, PHARMD 2802 61st Ave Ne Apt A104, Tacoma, WA 98422-3354 Ph: (253) 507-0076 | Jerome Kwaku Atror, PHARMD 11012 Canyon Rd E, Puyallup, WA 98373-4200 Ph: (253) 537-1517 |
News Archive
Cumberland Pharmaceuticals Inc. today announced that results from a clinical study evaluating the safety and efficacy of Caldolor Injection in treating fever and pain in hospitalized burn patients was published in Volume 32, Number 1 of the Journal of Burn Care & Research.
In its latest briefing on the H1N1 influenza A pandemic (swine flu), the World Health Organisation (WHO) says the unprecedented speed of the spread of the virus means reporting requirements and the data needed for risk assessment, both within affected countries and at the global level, are changing.
Beta blockers may boost survival in patients undergoing definitive radiotherapy for non-small-cell lung cancer, suggests research published in the Annals of Oncology.
A team of scientists, led by Dr. Krystof Bankiewicz, University of California-San Francisco, presented this significant advance, which allows, for the first time, to adjust parameters of vector infusion while delivering gene therapy, giving surgeon full control over gene transfer technology.
RegeneRx Biopharmaceuticals, Inc. announced today that it has been awarded a $3 million grant from the National Institutes of Health's National Heart, Lung and Blood Institute to support and accelerate the clinical development of its novel product candidate RGN-352, an injectable formulation of the novel therapeutic peptide Thymosin beta 4, or Tβ4, for patients who have suffered an acute myocardial infarction, or AMI, commonly known as a heart attack.
› Verified 1 days ago
Dennis W Zimmermann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 31st Ave Sw, Puyallup, WA 98373 Phone: 253-445-7100 | |
Erin Marie Rose, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13308 Meridian E, Puyallup, WA 98373 Phone: 253-435-1742 | |
Dr. Aiden Dai Tran, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11012 Canyon Rd E, Puyallup, WA 98373 Phone: 253-537-3770 | |
Jodi Moffitt, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10302 156th St E, 2136, Puyallup, WA 98374 Phone: 253-604-1066 | |
Gordon Baldwin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-1885 | |
Melissa Harvey, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1201 39th Ave Sw, Puyallup, WA 98373 Phone: 253-445-7542 Fax: 253-445-7549 | |
Rachel Singer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-4000 |